Calox has acquired Vitapharma, a Peruvian laboratory with a 5,500 m² plant in Lurín, as part of its expansion in the Andean region. Vitapharma, which had a turnover of US$1,400,000,000 in 2023, projected to reach US$1,400,000,000 in 2025 after its merger with Keyfarm and an investment of US$1,400,000,000,000 in expansion and equipment. With this purchase, Calox, which is present in 8 countries, is strengthening its growth in Latin America. UNE Asesores Financieros advised on the sale of the Peruvian laboratory Vitapharma by Calox.
